It has been demonstrated that cancer cells undergoing epithelial-mesenchymal transition (EMT), a hallmark of cancer, suppress NLRP3 inflammasome activities of tumor-associated macrophages (TAMs) in response to chemotherapy [181]. The gene discussed is NLRP3; the disease is cancer.